Skip to Main Content

Lloyd Friedman, MD

Critical Care Medicine, Pulmonology & Sleep Medicine
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine and Pulmonary Disease

Biography

Lloyd Friedman, MD, is a pulmonary critical care specialist who primarily treats tuberculosis, latent tuberculosis infection and nontuberculous mycobacteria. He also cares for critically ill patients in the intensive care unit at Yale New Haven Hospital.

A clinical professor of medicine (pulmonology), Dr. Friedman has been at Yale since 1989. The major focus of his research is an experimental project concerning the association of tuberculosis and asthma. He recently published the results of a multicenter trial investigating the incidence of reversion of latent tuberculosis infection through the use of skin tests and interferon gamma release assays.

Dr. Friedman has been following a cohort of welfare patients in New York to assess the incidence of tuberculosis, AIDS and death.

Titles

  • Professor
  • Director of Inpatient Quality and Safety, Internal Medicine

Education & Training

  • Fellow
    Yale University School of Medicine (1988)
  • Resident
    Oregon Health Sciences University (1982)
  • Intern
    Beth Israel Medical Center (1980)
  • MD
    Yale University (1979)
  • BA
    Columbia University, Biochemistry (1975)

Additional Information

Biography

Lloyd Friedman, MD, is a pulmonary critical care specialist who primarily treats tuberculosis, latent tuberculosis infection and nontuberculous mycobacteria. He also cares for critically ill patients in the intensive care unit at Yale New Haven Hospital.

A clinical professor of medicine (pulmonology), Dr. Friedman has been at Yale since 1989. The major focus of his research is an experimental project concerning the association of tuberculosis and asthma. He recently published the results of a multicenter trial investigating the incidence of reversion of latent tuberculosis infection through the use of skin tests and interferon gamma release assays.

Dr. Friedman has been following a cohort of welfare patients in New York to assess the incidence of tuberculosis, AIDS and death.

Titles

  • Professor
  • Director of Inpatient Quality and Safety, Internal Medicine

Education & Training

  • Fellow
    Yale University School of Medicine (1988)
  • Resident
    Oregon Health Sciences University (1982)
  • Intern
    Beth Israel Medical Center (1980)
  • MD
    Yale University (1979)
  • BA
    Columbia University, Biochemistry (1975)

Additional Information